Journal Information
Statistics
Follow this link to access the full text of the article
Original article
In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides
Evaluación de la actividad in vitro de ceftobiprol y dalbavancina frente a estafilococos coagulasa negativos con sensibilidad disminuida a daptomicina y/o resistentes a linezolid o glucopéptidos aislados de muestras clínicas
Silvia Velasco de la Fuente
, Marta Fernández-Martinez, Jesús Rodríguez Lozano, Daniel Pablo-Marcos, María Siller, Jorge Calvo
Corresponding author
Microbiology Service, University Hospital Marqués de Valdecilla – IDIVAL, Santander, Spain